Milan, Italy

Cesare Sirtori

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 3.4

ph-index = 5

Forward Citations = 83(Granted Patents)


Location History:

  • 1 Milan, IT (1984)
  • Milan, IT (1984 - 2003)

Company Filing History:


Years Active: 1984-2003

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Cesare Sirtori

Introduction

Cesare Sirtori is a notable inventor based in Milan, Italy. He has made significant contributions to the field of biotechnology, particularly in the development of pharmaceutical compositions. With a total of 6 patents to his name, Sirtori's work has the potential to impact the treatment of cardiovascular diseases.

Latest Patents

One of Sirtori's latest patents is focused on the dimer of a molecular variant of apolipoprotein. This invention involves the isolation and characterization of substantially pure dimers of Apolipoprotein AI-Milano (APO-AI-M/APO AI-M) from plasma. The dimer can also be produced in a recombinant system. The pharmaceutical compositions that include the ApoAI-AI-M/ApoAI-M dimer are designed for treating patients with atherosclerosis or cardiovascular diseases. Additionally, these medicaments can be utilized to prevent thrombosis in various clinical situations, both at the arterial and venous levels. The dimer also has the potential to act as a prodrug for the monomer.

Career Highlights

Throughout his career, Sirtori has worked with various organizations, contributing to advancements in pharmaceutical science. His innovative work has positioned him as a key figure in his field.

Collaborations

Sirtori has collaborated with notable individuals such as Carlo Scolastico and Guido Franceschini. These partnerships have further enhanced the impact of his research and inventions.

Conclusion

Cesare Sirtori's contributions to biotechnology and pharmaceutical compositions demonstrate his commitment to advancing medical science. His innovative patents have the potential to improve treatment options for patients with cardiovascular conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…